Sung, F.-C.; Yeh, Y.-T.; Muo, C.-H.; Hsu, C.-C.; Tsai, W.-C.; Hsu, Y.-H.
Statins Reduce Hepatocellular Carcinoma Risk in Patients with Chronic Kidney Disease and End-Stage Renal Disease: A 17-Year Longitudinal Study. Cancers 2022, 14, 825.
https://doi.org/10.3390/cancers14030825
AMA Style
Sung F-C, Yeh Y-T, Muo C-H, Hsu C-C, Tsai W-C, Hsu Y-H.
Statins Reduce Hepatocellular Carcinoma Risk in Patients with Chronic Kidney Disease and End-Stage Renal Disease: A 17-Year Longitudinal Study. Cancers. 2022; 14(3):825.
https://doi.org/10.3390/cancers14030825
Chicago/Turabian Style
Sung, Fung-Chang, Yi-Ting Yeh, Chih-Hsin Muo, Chih-Cheng Hsu, Wen-Chen Tsai, and Yueh-Han Hsu.
2022. "Statins Reduce Hepatocellular Carcinoma Risk in Patients with Chronic Kidney Disease and End-Stage Renal Disease: A 17-Year Longitudinal Study" Cancers 14, no. 3: 825.
https://doi.org/10.3390/cancers14030825
APA Style
Sung, F. -C., Yeh, Y. -T., Muo, C. -H., Hsu, C. -C., Tsai, W. -C., & Hsu, Y. -H.
(2022). Statins Reduce Hepatocellular Carcinoma Risk in Patients with Chronic Kidney Disease and End-Stage Renal Disease: A 17-Year Longitudinal Study. Cancers, 14(3), 825.
https://doi.org/10.3390/cancers14030825